ITI-1549
A synthetic opioid analgesic
ITI-1549 is a synthetic opioid analgesic that was developed for the treatment of moderate to severe pain. It is part of a class of drugs known as piperidine derivatives, which are characterized by their potent analgesic properties.
Chemical Structure[edit]
ITI-1549 is chemically classified as a piperidine derivative. Its IUPAC name is (3R,4R)-3-(Dimethylamino)-1-(2-phenylethyl)-4-(phenylthio)piperidine. The structure features a piperidine ring, which is a six-membered ring containing five carbon atoms and one nitrogen atom. The presence of a phenylthio group and a dimethylamino group contributes to its pharmacological activity.
Pharmacology[edit]
ITI-1549 acts primarily as an agonist at the mu-opioid receptor, which is responsible for its analgesic effects. Activation of this receptor leads to the inhibition of neurotransmitter release, resulting in decreased perception of pain. Like other opioids, ITI-1549 can produce side effects such as sedation, respiratory depression, and euphoria.
Clinical Use[edit]
ITI-1549 was developed for the management of moderate to severe pain, particularly in cases where other analgesics are ineffective. Its use is typically restricted to controlled clinical settings due to the potential for abuse and dependence associated with opioid medications.
Side Effects[edit]
Common side effects of ITI-1549 include nausea, vomiting, constipation, and drowsiness. More serious side effects can include respiratory depression, which can be life-threatening, especially in overdose situations. Long-term use can lead to tolerance and physical dependence.
Legal Status[edit]
The legal status of ITI-1549 varies by country, but it is generally classified as a controlled substance due to its potential for abuse and addiction. In many jurisdictions, it is available only by prescription and is subject to strict regulatory controls.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
